-
Product Insights
NewDelayed Graft Function (DGF) – Drugs In Development, 2024
Empower your strategies with our Delayed Graft Function (DGF) – Drugs In Development, 2024 report and make more profitable business decisions. Delayed graft function (DGF) is an indication of acute kidney injury (AKI) occurring after a kidney transplant, with attributes unique to the transplant process. AKI is defined as an increase in serum creatinine within 48 hours of an inciting event. In the case of a transplant, the timing is less straightforward. The diagnosis of DGF is complicated by a variety...
-
Product Insights
NewAcute Liver Failure – Drugs In Development, 2024
Empower your strategies with our Acute Liver Failure – Drugs In Development, 2024 report and make more profitable business decisions. Acute liver failure is a rare but life-threatening condition that occurs when the liver loses most of its function in a short period of time. It can be caused by various factors, such as viral infections, drug overdose, autoimmune diseases, or metabolic disorders. Some of the common signs and symptoms of acute liver failure are jaundice, bleeding, confusion, and coma. Acute...
-
Product Insights
NewLiver Failure (Hepatic Insufficiency) – Drugs In Development, 2024
Empower your strategies with our Liver Failure (Hepatic Insufficiency) – Drugs In Development, 2024 report and make more profitable business decisions. Liver failure is severe deterioration of liver function. Liver failure occurs when a large portion of the liver is damaged due to any type of liver disorder. Symptoms may include jaundice, tendency to bruise or bleed easily, ascites, impaired brain function (encephalopathy), poor weight gain and growth, fatigue, weakness, nausea, and loss of appetite. Since these symptoms are associated with...
-
Product Insights
Liver Failure (Hepatic Insufficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Liver failure is severe deterioration of liver function. Liver failure occurs when a large portion of the liver is damaged due to any type of liver disorder. Symptoms may include jaundice, a tendency to bruise or bleed easily, ascites, impaired brain function (encephalopathy), poor weight gain and growth, fatigue, weakness, nausea, and loss of appetite. Since these symptoms are associated with a host of other conditions, it may take some time before the correct diagnosis is made. As liver failure...
-
Product Insights
Non-Alcoholic Steatohepatitis (NASH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-alcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. NASH can get worse and cause scarring of the liver, which leads to cirrhosis. Symptoms of NASH include fatigue, weight loss for no clear reason, general weakness and an ache in the upper right part of belly. Risk factors include obesity, type 2 diabetes, high cholesterol and high triglycerides and metabolic syndrome. The NASH drugs in development market research report provides comprehensive information on the...